Adult Diffuse Astrocytoma Completed Phase 1 Trials for Erlotinib (DB00530)

IndicationStatusPhase
DBCOND0029697 (Adult Diffuse Astrocytoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00030498Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionTreatment